NCT04831203View on ClinicalTrials.gov

NWT-03 and Brain Function

NACompletedINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

April 23, 2021

Primary Completion Date

October 24, 2022

Study Completion Date

October 24, 2022

Conditions

Brain Vascular FunctionCognition

Interventions

DIETARY_SUPPLEMENT

An egg-protein hydrolysate (NWT-03)

As described in the experimental arm

DIETARY_SUPPLEMENT

Placebo

As described in the Control arm

Trial Locations (1)

6211 LK

Maastricht University, Maastricht

All Listed Sponsors

lead

Maastricht University Medical Center

OTHER